Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects

ABSTRACT: This is a randomized, double-blind, single-dose, parallel-group study comparing pharmacokinetic characteristics, safety , tolerability and immunogenicity of LY01008 (Recombinant Humanized Anti-Human Vascular Endothelial Growth Factor Monoclonal Antibody Injection) and Avastin (Bevacizumab Injection) in healthy Chinese male subjects.

DISEASE(S): Non Small Cell Lung Cancer Recurrent,Metastatic Colorectal Cancer,Carcinoma, Non-small-cell Lung,Lung Neoplasms,Non Small Cell Lung Cancer Metastatic

PROVIDER: 2394704 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR